RIGEL PHARMACEUTICALS INC: AMERICAN CENTURY INVESTMENT MANAGEMENT INC discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
American Century Investment Management Inc. disclosed a stake of more than 5% in Rigel Pharmaceuticals Inc. in a Schedule 13G filing with the SEC (accession 0000052388-26-000507). The filing signals that the asset manager has crossed the 5% beneficial ownership threshold, making it a reportable large holder in the biopharmaceutical company. The exact share count and percentage were not specified in the headline disclosure. The move matters because 13G filings flag passive or institutional accumulation that can influence governance and liquidity in a small-cap stock. Investors will watch for the full filing details, including precise ownership figures and any subsequent 13G amendments.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
American Century Investment Management Inc, Rigel Pharmaceuticals Inc